Donington Jessica S, Miller Daniel L, Rowland Charles C, Deschamps Claude, Allen Mark S, Trastek Victor F, Pairolero Peter C
Division of General Thoracic Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
Ann Thorac Surg. 2002 Jul;74(1):154-8; discussion 158-9. doi: 10.1016/s0003-4975(02)03688-3.
Patients who have undergone a pneumonectomy for bronchogenic carcinoma are at risk of cancer in the contralateral lung. Little information exists regarding the outcome of subsequent lung operation for lung cancer after pneumonectomy.
The records of all patients who underwent lung resection after pneumonectomy for lung cancer from January 1980 through July 2001 were reviewed.
There were 24 patients (18 men and 6 women). Median age was 64 years (range, 43 to 84 years). Median preoperative forced expiratory volume in 1 second was 1.47 L (range, 0.66 to 2.55 L). Subsequent pulmonary resection was performed 2 to 213 months after pneumonectomy (median, 23 months). Wedge excision was performed in 20 patients, segmentectomy in 3, and lobectomy in 1. Diagnosis was a metachronous lung cancer in 14 patients and metastatic lung cancer in 10. Complications occurred in 11 patients (44.0%), and 2 died (operative mortality, 8.3%). Median hospitalization was 7 days (range, 2 to 72 days). Follow-up was complete in all patients and ranged between 6 and 140 months (median, 37 months). Overall 1-, 3-, and 5-year survivals were 87%, 61%, and 40%, respectively. Five-year survival of patients undergoing resection for a metachronous lung cancer (50%) was better than the survival of patients who underwent resection for metastatic cancer (14%; p = 0.14). Five-year survival after a solitary wedge excision was 46% compared with 25% after a more extensive resection (p = 0.54).
Limited pulmonary resection of the contralateral lung after pneumonectomy is associated with acceptable morbidity and mortality. Long-term survival is possible, especially in patients with a metachronous cancer. Solitary wedge excision is the treatment of choice.
因支气管源性癌接受肺叶切除术的患者,对侧肺有发生癌症的风险。关于肺叶切除术后后续肺癌手术的结果,现有信息较少。
回顾了1980年1月至2001年7月期间因肺癌接受肺叶切除术后行肺切除术的所有患者的记录。
共有24例患者(18例男性和6例女性)。中位年龄为64岁(范围43至84岁)。术前1秒用力呼气量中位数为1.47L(范围0.66至2.55L)。肺叶切除术后2至213个月(中位时间23个月)进行了后续肺切除术。20例行楔形切除术,3例行肺段切除术,1例行肺叶切除术。14例诊断为异时性肺癌,10例为转移性肺癌。11例患者发生并发症(44.0%),2例死亡(手术死亡率8.3%)。中位住院时间为7天(范围2至72天)。所有患者均完成随访,随访时间为6至140个月(中位时间37个月)。总体1年、3年和5年生存率分别为87%、61%和40%。异时性肺癌切除患者的5年生存率(50%)高于转移性癌切除患者的生存率(14%;p = 0.14)。孤立楔形切除术后5年生存率为46%,而广泛切除术后为25%(p = 0.54)。
肺叶切除术后对侧肺有限的肺切除术与可接受的发病率和死亡率相关。长期生存是可能的,尤其是异时性癌症患者。孤立楔形切除术是首选治疗方法。